BPC-157 acts via the NO system, EGF/VEGF, gastroprotection, and neuroprotection
10 mg = 10,000 mcg 10,000 mcg / 2 mL = 5,000 mcg/mL 500 mcg / 5,000 mcg per mL = 0.1 mL = 10 U-100 units BPC-157 dose in units and mL "Units" and "mL" describe the same draw two ways
Age-related changes in renal function, hepatic metabolism, and tissue perfusion theoretically could influence peptide clearance and distribution, though no studies have systematically examined age effects
The Gray Market Problem Most peptides beyond the FDA-approved weight-loss drugs require purchasing from gray-market online suppliers
This allows the peptide to act on the central nervous system (CNS) when applied via injection or intranasally [3]
Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system